Disclosed is a nanobody against the human programmed death factor PD-LI. The antibody has the function of blocking the binding of PD-LI to the receptor PD-I. Disclosed are the nanobody and the gene sequence encoding the nanobody, the corresponding expression vector and the host cell capable...
Rabbit IgG nanobody, Rabbit IgG nanobodies价格:价格电议产品详情:温馨提示:优宁维所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)! ... 纯度:见优宁维官网% 包装规格:见优宁维官网 用途:详见说明书 ...
Anti-Human CD274/PD-L1/B7-H1 Nanobody (SAA1177)|抗 HUMAN CD274/PD-L1/B7-H1 纳米抗体 (SAA1177)(RHJ70101) 基本信息 更多信息 中文名称: 抗HUMAN CD274/PD-L1/B7-H1 纳米抗体 (SAA1177)(RHJ70101) 中文同义词: 抗HUMAN CD274/PD-L1/B7-H1 纳米抗体 (SAA1177)(RHJ70101) 英文名称: Anti-Human...
ChemicalBook provide Chemical industry users with Anti-Human CD274/PD-L1/B7-H1 Nanobody (SAA0904) Boiling point Melting point,Anti-Human CD274/PD-L1/B7-H1 Nanobody (SAA0904) Density MSDS Formula Use,If You also need to Anti-Human CD274/PD-L1/B7-H1 Nanobo
single-domain antibody (sdAb, nanobody) cancer phage display immunoglobulin-like domain immunotherapy programmed death-ligand 1 programmed cell death protein 1 Cluster of differentiation 80 Abbreviations BLI biolayer interferometry CDR complementary determining region PDB Protein Data Bank ...
(free GDF-15 plus visugromab-GDF-15 complex) during treatment were determined by a validated ECL method, using a custom visugromab non-competitive anti-GDF-15 nanobody as a capture reagent and, following saturation with visugromab, a custom non-competitive anti-visugromab an...
Provided in the present invention are a type of anti-human PD-L1 specific nanobodies and VHH chains thereof, coding sequences of the foregoing nanobodies or VHH chains thereof, corresponding expression vectors and host cells, and a method for producing antibodies.Hong Hoi Ting...
Provided in the present invention are a type of anti-human PD-L1 specific nanobodies and VHH chains thereof, coding sequences of the foregoing nanobodies or VHH chains thereof, corresponding expression vectors and host cells, and a method for producing antibodies.Hong Hoi Ting...
Disclosed is a nanobody against the human programmed death factor PD-L1. The antibody has the function of blocking the binding of PD-L1 to the receptor PD-1. Disclosed are the nanobody and the gene sequence encoding the nanobody, the corresponding expression vector and the host cell capable...
The anti-PD-L1 nanobody and an Fc fusion protein thereof are strong in specificity, high in affinity, and weak in immunogenicity in humans, and has a remarkable anti-tumor effect. The trifunctional fusion protein comprises a TGF-尾 inhibitor, a VEGF inhibitor and a PD-L1 inhibiting antibody...